Pádraig Rice

334. Deputy Pádraig Rice asked the Minister for Health with regard to the new nicotine inhaling products Bill, her plans in respect of flavours; if consideration has been given to people with allergies (details supplied); and if she will make a statement on the matter. [25052/25]

106. Deputy Pádraig Rice asked the Minister for Housing, Local Government and Heritage if he will respond to matters raised in correspondence (details supplied); if he will request his Department to investigate this matter to ensure that all inspections are fulfilling their legal obligations; and if he will make a statement on the matter. [24714/25]

175. Deputy Pádraig Rice asked the Minister for Children, Disability and Equality further to Parliamentary Question No. 1897 of 29 April 2025, when the review to the provision of core funding scheme will take place; and if she will make a statement on the matter. [24743/25]

199. Deputy Pádraig Rice asked the Minister for Health to provide further details in respect of the role and responsibilities of the new HSCP regional integration development leads in each HSE health region; and if she will make a statement on the matter. [24701/25]

200. Deputy Pádraig Rice asked the Minister for Health if she will direct Children’s Health Ireland to carry out a retrospective communication campaign to formally notify all families of children and young people who have ever received MAGEC rod implants of a field safety notice (FSN) issued by a manufacturer in December 2021, including those patients whose rods have been removed or who have aged out of paediatric care (details supplied); if she will ensure that personalised correspondence are issued to disclose the clinical significance of this FSN, including the reduced recommended implantation duration and associated risks; that appropriate clinical follow-up and advice is offered to all affected individuals, in line with specific regulations and standards; and if she will make a statement on the matter. [24702/25]

201. Deputy Pádraig Rice asked the Minister for Health if she will provide a detailed breakdown of the total number of children and young people in Ireland who have received MAGEC rod implants, in tabular form; the number that currently have MAGEC rods left to fuse in situ; and the number that have aged out of paediatric care with MAGEC rods still in place; and if she will make a statement on the matter. [24703/25]

202. Deputy Pádraig Rice asked the Minister for Health if she will publish the clinical rationale for the approach of leaving MAGEC rod implants in situ beyond the two-year implantation period recommended by the manufacturer in the December 2021 field safety notice (details supplied); and if she will make a statement on the matter. [24704/25]

203. Deputy Pádraig Rice asked the Minister for Health if Children’s Health Ireland obtained explicit, informed consent from each family prior to a clinical decision being made to leave MAGEC rods in place to fuse in situ; if this consent process included the provision of written information outlining the known increased risks of adverse events associated with prolonged implantation beyond two years as required (details supplied); and if she will make a statement on the matter. [24705/25]

204. Deputy Pádraig Rice asked the Minister for Health if the use of MAGEC rods left to fuse in situ beyond two years in patients under the care of Children’s Health Ireland (CHI), contrary to the manufacturer’s instructions for use, was treated as off-label use under EU Medical Devices Regulation (MDR) 2017/745; if CHI ensured that a documented clinical justification was made; if families received written information explaining the off-label use and associated risks; if specific informed consent was obtained in line with legal obligations under MDR and national policy; and if she will make a statement on the matter. [24706/25]

205. Deputy Pádraig Rice asked the Minister for Health if any cases involving the off-label use of MAGEC rods were reviewed by clinical governance structures, ethics committees, or hospital risk management teams within Children’s Health Ireland (CHI) (details supplied); if not, if she will now require CHI to carry out a retrospective audit of these cases to ensure regulatory and ethical compliance; and if she will make a statement on the matter. [24707/25]

206. Deputy Pádraig Rice asked the Minister for Health if Children’s Health Ireland (CHI) routinely monitors blood levels of titanium, cobalt, and chromium in patients with MAGEC rods left to fuse in situ, in light of CHI's own findings (details supplied); if she will publish CHI's clinical policy for the follow-up and monitoring of patients who have aged out of paediatric care with MAGEC rods still in place, including access to adult services for ongoing review and surveillance; and if she will make a statement on the matter. [24708/25]

207. Deputy Pádraig Rice asked the Minister for Health the number of vigilance reports or device-related incident notifications which have been submitted by Children’s Health Ireland (CHI) or the HSE to the Health Products Regulatory Authority in relation to MAGEC rods since the implementation of EU Medical Devices Regulation (MDR) 2017/745; if she will publish a breakdown of the nature of adverse events or faults reported, including mechanical failure, metallosis, or off-label use; and if she will make a statement on the matter. [24709/25]

208. Deputy Pádraig Rice asked the Minister for Health the reason MAGEC rods remain unapproved for general use in Ireland and are only accessible under compassionate grounds; if she will publish the clinical and regulatory rationale for this continued restriction, including any safety concerns identified by the Health Products Regulatory Authority or other regulatory bodies; the steps being taken to assess the safety and efficacy of MAGEC rods for potential future approval; and if she will make a statement on the matter. [24710/25]

209. Deputy Pádraig Rice asked the Minister for Health if Children’s Health Ireland and associated paediatric spinal services record and report deaths of children and young people following scoliosis surgery using internationally recognised postoperative timeframes, including 30-day and 90-day mortality and in-hospital death; if she will publish all available data on postoperative mortality following scoliosis surgery in Ireland over the last ten years, including deaths occurring after discharge, to ensure comprehensive oversight of surgical outcomes and compliance with national and international safety reporting standards; if any of these deaths were reported through internal risk systems or to the Health Products Regulatory Authority under post-market surveillance obligations; and if she will make a statement on the matter. [24711/25]

212. Deputy Pádraig Rice asked the Minister for Health if funding will be provided for an all-island defibrillator registry (details supplied); if so, the timeline for same; the engagement she has had with her counterparts in Northern Ireland in respect of this project;; and if she will make a statement on the matter. [24720/25]

115. Deputy Pádraig Rice asked the Minister for Health if her attention has been drawn to a series of investigative reports into transgender healthcare in Ireland (details supplied); if she will commit to reclassifying trans healthcare as part of sexual health rather than mental health, in line with the World Health Organization; to provide an update on the new model of care currently being developed; and if she will make a statement on the matter. [24053/25]

118. Deputy Pádraig Rice asked the Minister for Health the date on which she will publish the new national sexual health strategy; the reason for the continued delay in doing so; and if she will make a statement on the matter. [24091/25]

123. Deputy Pádraig Rice asked the Minister for Health to provide an update on the programme for Government commitment to design a statutory home care scheme, the timeline she is working towards, and if she will make a statement on the matter. [24093/25]

161. Deputy Pádraig Rice asked the Minister for Health if she will commit to introducing health warning labels on alcohol products in May 2026; her views on her Cabinet colleagues’ comments in relation to delaying this measure; and if she will make a statement on the matter. [24090/25]

171. Deputy Pádraig Rice asked the Minister for Health the status of the Programme for Government commitment to explore the recruitment of HSE-employed GPs; and if she will make a statement on the matter. [24092/25]

230. Deputy Pádraig Rice asked the Minister for Health her views on the HSE’s growing reliance on outsourcing radiotherapy services to private providers; the steps she is taking to reverse this trend; and if she will make a statement on the matter. [24089/25]

561. Deputy Pádraig Rice asked the Minister for Education and Youth to reply to matters raised in correspondence (details supplied); if the Department will reconsider this decision; the reasons as to why this decision was communicated so late in the school year; and if she will make a statement on the matter. [23286/25]

593. Deputy Pádraig Rice asked the Minister for Education and Youth regarding circular 0032/2017, if her Department is aware that schools are instructing parents to purchase laptops only through exclusive suppliers; if consideration will be given to introduce measures to limit this practice; and if she will make a statement on the matter. [23971/25]

1014. Deputy Pádraig Rice asked the Minister for Health to provide further details regarding the traction system referred to in HIQA’s review on governance of implantable medical devices at Children’s Health Ireland (CHI), including use of non-CE marked springs in surgery at CHI Temple Street (details supplied); the number of children it was used on; if it was CE marked; and if she will make a statement on the matter. [23284/25]

1015. Deputy Pádraig Rice asked the Minister for Health the timeline she is working towards in publishing the national treatment purchase fund review of the nursing home pricing system, given that the programme for Government commits to doing so in early 2025; and if she will make a statement on the matter. [23285/25]